Why is JFL Life falling/rising?

As of 18-Aug, JFL Life Sciences Ltd is experiencing a decline in its stock price, currently at Rs 13.00, reflecting a decrease of Rs 0.55 or 4.06%. The stock is trading close to its 52-week low, just 0.38% away from Rs 12.95, and has underperformed its sector by 4.29% today. Over the past week, the stock has dropped by 7.47%, and its year-to-date performance shows a significant decline of 57.72%. Despite a healthy long-term growth rate in operating profit of 34.76% and a return on capital employed (ROCE) of 17.5%, the stock has generated a staggering return of -77.01% over the past year, indicating a troubling trend. Additionally, net sales for the recent quarter fell by 27.8% compared to the previous four-quarter average, contributing to the stock's poor performance. In the broader market context, JFL Life's short-term performance contrasts sharply with the Sensex, which has gained 1.19% over the past week. The stock's significant underperformance relative to the benchmark and the BSE500 over various time frames highlights a concerning trend for investors. While there has been a rise in investor participation, with delivery volume increasing by 37.5% against the five-day average, the overall sentiment remains negative due to the company's flat results and below-par performance both in the near term and long term. This combination of factors suggests that investors are cautious, leading to the stock's continued decline.